• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在反 miRNA 寡核苷酸的 3' 末端进行酯修饰可提高 miRNA 抑制的效力。

Ester modification at the 3' end of anti-microRNA oligonucleotides increases potency of microRNA inhibition.

机构信息

Department of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, United States.

Department of Chemistry, University of California, One Shields Avenue, Davis, CA 95616, United States.

出版信息

Bioorg Med Chem. 2021 Jan 1;29:115894. doi: 10.1016/j.bmc.2020.115894. Epub 2020 Nov 28.

DOI:10.1016/j.bmc.2020.115894
PMID:33290908
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8610567/
Abstract

MicroRNAs (miRNAs) are short noncoding RNAs that play a fundamental role in gene regulation. Deregulation of miRNA expression has a strong correlation with disease and antisense oligonucleotides that bind and inhibit miRNAs associated with disease have therapeutic potential. Current research on the chemical modification of anti-miRNA oligonucleotides (anti-miRs) is focused on alterations of the phosphodiester-ribose backbone to improve nuclease resistance and binding affinity to miRNA strands. Here we describe a structure-guided approach for modification of the 3'-end of anti-miRs by screening for modifications compatible with a nucleotide-binding pocket present on human Argonaute2 (hAgo2). We computationally screened a library of 190 triazole-modified nucleoside analogs for complementarity to the t1A-binding pocket of hAgo2. Seventeen top scoring triazoles were then incorporated into the 3' end of anti-miR21 and potency was evaluated for each in a cell-based assay for anti-miR activity. Four triazole-modified anti-miRs showed higher potency than anti-miR21 bearing a 3' adenosine. In particular, a triazole-modified nucleoside bearing an ester substituent imparted a nine-fold and five-fold increase in activity for both anti-miR21 and anti-miR122 at 300 and 5 nM, respectively. The ester group was shown to be critical as a similar carboxylic acid and amide were inactive. Furthermore, anti-miR 3' end modification with triazole-modified nucleoside analogs improved resistance to snake venom phosphodiesterase, a 3'-exonuclease. Thus, the modifications described here are good candidates for improvement of anti-miR activity.

摘要

MicroRNAs (miRNAs) 是短链非编码 RNA,在基因调控中发挥着重要作用。miRNA 表达失调与疾病密切相关,与疾病相关的 miRNA 结合并抑制 miRNA 的反义寡核苷酸具有治疗潜力。目前,抗 miRNA 寡核苷酸(anti-miRs)的化学修饰研究集中在磷酸二酯-核糖骨架的改变上,以提高核酸酶抗性和与 miRNA 链的结合亲和力。在这里,我们描述了一种通过筛选与存在于人 Argonaute2(hAgo2)上的核苷酸结合口袋相容的修饰来修饰 anti-miRs 3'端的结构导向方法。我们通过计算筛选了一个包含 190 个三唑修饰核苷类似物的文库,以与 hAgo2 的 t1A 结合口袋互补。然后将 17 个得分最高的三唑并入 anti-miR21 的 3'端,并在基于细胞的抗 miR 活性测定中评估每种化合物的效力。四种三唑修饰的 anti-miRs 比带有 3'腺嘌呤的 anti-miR21 具有更高的效力。特别是,带有酯取代基的三唑修饰核苷赋予了 anti-miR21 和 anti-miR122 在 300 和 5 nM 时的活性分别提高了九倍和五倍。酯基是关键的,因为类似的羧酸和酰胺是无活性的。此外,三唑修饰的核苷类似物对蛇毒磷酸二酯酶(一种 3'-外切核酸酶)的修饰改善了 anti-miR 的抗性。因此,这里描述的修饰是提高 anti-miR 活性的良好候选物。

相似文献

1
Ester modification at the 3' end of anti-microRNA oligonucleotides increases potency of microRNA inhibition.在反 miRNA 寡核苷酸的 3' 末端进行酯修饰可提高 miRNA 抑制的效力。
Bioorg Med Chem. 2021 Jan 1;29:115894. doi: 10.1016/j.bmc.2020.115894. Epub 2020 Nov 28.
2
Nuclease resistant methylphosphonate-DNA/LNA chimeric oligonucleotides.耐核酸酶的甲基膦酸酯-DNA/LNA嵌合寡核苷酸。
Bioorg Med Chem Lett. 2009 May 15;19(10):2707-9. doi: 10.1016/j.bmcl.2009.03.116. Epub 2009 Mar 28.
3
Antagonists of the miRNA-Argonaute 2 Protein Complex: Anti-miR-AGOs.微小RNA-AGO2蛋白复合物拮抗剂:抗miR-AGO
Methods Mol Biol. 2017;1517:239-249. doi: 10.1007/978-1-4939-6563-2_17.
4
Nuclease resistance and antisense activity of modified oligonucleotides targeted to Ha-ras.靶向Ha-ras的修饰寡核苷酸的核酸酶抗性和反义活性
J Biol Chem. 1996 Jun 14;271(24):14533-40. doi: 10.1074/jbc.271.24.14533.
5
Synthetic nucleosides and nucleotides. 37. Antisense oligodeoxynucleotides bearing 5-(phenylethyl)-2'-deoxyuridylate at the 3'-terminus: exonuclease-resistant molecule with natural phosphodiester backbone.合成核苷和核苷酸。37. 3'-末端带有5-(苯乙基)-2'-脱氧尿苷酸的反义寡脱氧核苷酸:具有天然磷酸二酯主链的抗核酸外切酶分子。
J Pharm Sci. 1996 Aug;85(8):815-8. doi: 10.1021/js9600843.
6
Potent and sustained cellular inhibition of miR-122 by lysine-derivatized peptide nucleic acids (PNA) and phosphorothioate locked nucleic acid (LNA)/2'-O-methyl (OMe) mixmer anti-miRs in the absence of transfection agents.在无转染试剂的情况下,赖氨酸衍生的肽核酸(PNA)以及硫代磷酸锁定核酸(LNA)/2'-O-甲基(OMe)混合寡核苷酸对miR-122具有强大且持续的细胞抑制作用。
Artif DNA PNA XNA. 2011 Jul-Dec;2(3):71-8. doi: 10.4161/adna.17731.
7
Anti-miRs competitively inhibit microRNAs in Argonaute complexes.抗miR在AGO蛋白复合体中竞争性抑制微小RNA。
PLoS One. 2014 Jul 3;9(7):e100951. doi: 10.1371/journal.pone.0100951. eCollection 2014.
8
Evaluation of different types of end-capping modifications on the stability of oligonucleotides toward 3'- and 5'-exonucleases.评估不同类型的封端修饰对寡核苷酸抵抗3'-和5'-核酸外切酶稳定性的影响。
Nucleosides Nucleotides. 1999 Sep;18(9):2051-69. doi: 10.1080/07328319908044864.
9
Improved targeting of miRNA with antisense oligonucleotides.利用反义寡核苷酸改善对微小RNA的靶向作用。
Nucleic Acids Res. 2006 May 11;34(8):2294-304. doi: 10.1093/nar/gkl183. Print 2006.
10
Synthesis of 2'-O-[2-[(N,N-dimethylamino)oxy]ethyl] modified nucleosides and oligonucleotides.2'-O-[2-[(N,N-二甲基氨基)氧基]乙基]修饰核苷和寡核苷酸的合成
J Org Chem. 2002 Jan 25;67(2):357-69. doi: 10.1021/jo0103975.

引用本文的文献

1
microRNA-875-5p-conjugated gold nanoparticles suppress breast cancer progression through the MTDH/PTEN/AKT signaling pathway.微小RNA-875-5p偶联的金纳米颗粒通过MTDH/PTEN/AKT信号通路抑制乳腺癌进展。
Discov Oncol. 2024 Dec 18;15(1):804. doi: 10.1007/s12672-024-01626-5.
2
The potential use of microRNAs as a therapeutic strategy for SARS-CoV-2 infection.微小RNA作为治疗新型冠状病毒2019感染的一种治疗策略的潜在用途。
Arch Virol. 2021 Oct;166(10):2649-2672. doi: 10.1007/s00705-021-05152-5. Epub 2021 Jul 19.

本文引用的文献

1
Highly efficient silencing of microRNA by heteroduplex oligonucleotides.异源双链寡核苷酸高效沉默 microRNA。
Nucleic Acids Res. 2019 Aug 22;47(14):7321-7332. doi: 10.1093/nar/gkz492.
2
Regulation of microRNA function in animals.动物中 microRNA 功能的调控。
Nat Rev Mol Cell Biol. 2019 Jan;20(1):21-37. doi: 10.1038/s41580-018-0045-7.
3
Function Control of Anti-microRNA Oligonucleotides Using Interstrand Cross-Linked Duplexes.使用链间交联双链体对抗微小RNA寡核苷酸进行功能控制。
Mol Ther Nucleic Acids. 2018 Mar 2;10:64-74. doi: 10.1016/j.omtn.2017.11.003. Epub 2017 Nov 14.
4
Effective Anti-miRNA Oligonucleotides Show High Releasing Rate of MicroRNA from RNA-Induced Silencing Complex.有效的抗 miRNA 寡核苷酸显示出从 RNA 诱导沉默复合物中释放 miRNA 的高释放率。
Nucleic Acid Ther. 2017 Oct;27(5):303-308. doi: 10.1089/nat.2017.0663. Epub 2017 Sep 6.
5
Development of Novel Antisense Oligonucleotides for the Functional Regulation of RNA-Induced Silencing Complex (RISC) by Promoting the Release of microRNA from RISC.通过促进微小RNA从RNA诱导沉默复合体(RISC)中释放来开发用于功能性调节RNA诱导沉默复合体(RISC)的新型反义寡核苷酸。
Bioconjug Chem. 2015 Dec 16;26(12):2454-60. doi: 10.1021/acs.bioconjchem.5b00501. Epub 2015 Nov 8.
6
Water-mediated recognition of t1-adenosine anchors Argonaute2 to microRNA targets.水介导的t1-腺苷识别将Argonaute2锚定到微小RNA靶标上。
Elife. 2015 Sep 11;4:e07646. doi: 10.7554/eLife.07646.
7
Structural basis for microRNA targeting.microRNA 靶向作用的结构基础。
Science. 2014 Oct 31;346(6209):608-13. doi: 10.1126/science.1258040.
8
Phosphorothioates, essential components of therapeutic oligonucleotides.硫代磷酸酯,治疗性寡核苷酸的重要组成部分。
Nucleic Acid Ther. 2014 Dec;24(6):374-87. doi: 10.1089/nat.2014.0506.
9
Anti-miRs competitively inhibit microRNAs in Argonaute complexes.抗miR在AGO蛋白复合体中竞争性抑制微小RNA。
PLoS One. 2014 Jul 3;9(7):e100951. doi: 10.1371/journal.pone.0100951. eCollection 2014.
10
Development of microRNA therapeutics is coming of age.微小RNA疗法正在走向成熟。
EMBO Mol Med. 2014 Jul;6(7):851-64. doi: 10.15252/emmm.201100899.